GWAAIS 2022 Academic Conference Series - May
Lecture will be focused on mast cell activation syndrome. This is a disease with multiple symptoms involving different organ systems which can be difficult to diagnose and challenging to manage and treat.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and Greater Washington Allergy, Asthma and Immunology Society (GWAAIS). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.”.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists, fellows- in- training in allergy and immunology, primary care physicians, and allied health care providers in the field of allergy and immunology.
Learning Objectives
Upon completion of this activity, participants should be able to:
Appropriately diagnose atopic dermatitis. Actively manage and treat atopic dermatitis using medical and topical therapeutics. Actively manage and treat atopic dermatitis using immunomodulating therapies to include monoclonal antibodies.
Greater Washington Allergy, Asthma and Immunology Society
Second Academic Conference Series 2022
May 18, 2022
The Hilton McLean Tysons Corner | 7920 Jones Branch Drive, McLean, Virginia| (703) 847-5000
AGENDA
6:00pm-7:00pm Exhibits | Registration | Reception
7:00pm-7:15pm Welcome & Introduction
Theodore T. Kim, MD – President, GWAAIS
7:15pm-8:15pm “Updates on Atopic Dermatitis”
Speaker: Dr. Donald Leung, Division Head, Pediatric Allergy & Immunology
National Jewish Health
8:15pm-8:30pm Questions and Answer Session.
8:30pm Adjourn.
All identified conflicts of interest have been mitigated.
The individuals listed below disclose the following financial relationships:
Donald Leung, MD, speaker
Consultant: Boehringer Ingelheim, Genentech, Leo Pharma, Incyte
Researcher: Sanofi Genzyme
Theodore Kim, MD, planner
No relevant financial relationships to disclose
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma and Immunology (ACAAI) and the Greater Washington Allergy, Asthma and Immunology Society (GWAAIS). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation
The American College of Allergy, Asthma and Immunology (ACAAI) designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In compliance with the Americans with Disabilities Act, GWAAIS requests that any participant in need of accommodation contact Kay Kim, email: GWAAISDMV@gmail.com
Available Credit
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Attendance